Barclays PLC Invitae Corp Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.01 - $0.61 $3,840 - $234,294
-384,089 Reduced 91.18%
37,151 $0
Q4 2023

Feb 15, 2024
SELL
$0.42 - $0.72 $203,402 - $348,689
-484,291 Reduced 53.48%
421,240 $264,000
Q3 2023

Nov 07, 2023
BUY
$0.6 - $1.53 $475,254 - $1.21 Million
792,091 Added 698.25%
905,531 $548,000
Q2 2023

Aug 03, 2023
SELL
$1.05 - $1.63 $109,217 - $169,547
-104,017 Reduced 47.83%
113,440 $127,000
Q1 2023

May 04, 2023
BUY
$1.2 - $2.73 $3,592 - $8,173
2,994 Added 1.4%
217,457 $295,000
Q4 2022

Feb 13, 2023
BUY
$1.71 - $3.61 $128,686 - $271,670
75,255 Added 54.06%
214,463 $398,000
Q3 2022

Nov 03, 2022
SELL
$1.9 - $8.63 $61,352 - $278,671
-32,291 Reduced 18.83%
139,208 $343,000
Q2 2022

Aug 12, 2022
SELL
$2.13 - $9.01 $224,772 - $950,798
-105,527 Reduced 38.09%
171,499 $419,000
Q1 2022

May 16, 2022
SELL
$6.28 - $15.59 $463,564 - $1.15 Million
-73,816 Reduced 21.04%
277,026 $2.21 Million
Q4 2021

Feb 14, 2022
BUY
$14.7 - $28.67 $3.01 Million - $5.86 Million
204,536 Added 139.8%
350,842 $5.36 Million
Q3 2021

Nov 09, 2021
SELL
$24.31 - $33.6 $1.06 Million - $1.46 Million
-43,421 Reduced 22.89%
146,306 $4.16 Million
Q2 2021

Aug 13, 2021
BUY
$26.09 - $40.4 $104,151 - $161,276
3,992 Added 2.15%
189,727 $6.4 Million
Q1 2021

May 13, 2021
BUY
$33.06 - $56.93 $3.74 Million - $6.44 Million
113,189 Added 156.02%
185,735 $7.1 Million
Q4 2020

Feb 11, 2021
BUY
$39.09 - $57.4 $733,992 - $1.08 Million
18,777 Added 34.92%
72,546 $3.03 Million
Q3 2020

Nov 12, 2020
SELL
$28.43 - $44.67 $3.87 Million - $6.09 Million
-136,233 Reduced 71.7%
53,769 $2.33 Million
Q2 2020

Aug 12, 2020
BUY
$11.71 - $30.29 $1.07 Million - $2.77 Million
91,297 Added 92.49%
190,002 $5.76 Million
Q1 2020

May 13, 2020
SELL
$7.64 - $27.5 $479,486 - $1.73 Million
-62,760 Reduced 38.87%
98,705 $1.35 Million
Q4 2019

Feb 10, 2020
BUY
$15.02 - $20.57 $942,459 - $1.29 Million
62,747 Added 63.56%
161,465 $2.6 Million
Q3 2019

Nov 14, 2019
SELL
$18.85 - $27.5 $247,858 - $361,597
-13,149 Reduced 11.75%
98,718 $1.9 Million
Q2 2019

Aug 14, 2019
BUY
$17.37 - $26.27 $788,736 - $1.19 Million
45,408 Added 68.32%
111,867 $2.63 Million
Q1 2019

May 15, 2019
BUY
$10.65 - $25.75 $40,139 - $97,051
3,769 Added 6.01%
66,459 $1.56 Million
Q4 2018

Feb 14, 2019
SELL
$9.26 - $16.38 $70,524 - $124,750
-7,616 Reduced 10.83%
62,690 $694,000
Q3 2018

Nov 14, 2018
BUY
$7.54 - $18.31 $269,773 - $655,113
35,779 Added 103.63%
70,306 $1.18 Million
Q2 2018

Aug 14, 2018
BUY
$4.87 - $8.42 $124,701 - $215,602
25,606 Added 287.03%
34,527 $255,000
Q1 2018

May 15, 2018
BUY
$4.69 - $10.05 $10,130 - $21,708
2,160 Added 31.95%
8,921 $41,000
Q4 2017

Feb 14, 2018
BUY
$7.86 - $9.99 $45,863 - $58,291
5,835 Added 630.13%
6,761 $61,000
Q3 2017

Nov 14, 2017
BUY
$8.89 - $10.4 $8,232 - $9,630
926
926 $9,000

Others Institutions Holding NVTA

# of Institutions
20
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email